LABETALOL (TRANDATE, GLAXO-INC - NORMODYNE, SCHERING-CORP)

被引:9
作者
CARTER, BL
机构
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1983年 / 17卷 / 10期
关键词
D O I
10.1177/106002808301701001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:704 / 712
页数:9
相关论文
共 129 条
[51]   ANTI-HYPERTENSIVE EFFICACY OF COMBINED ALPHA-ADRENORECEPTOR AND BETA-ADRENORECEPTOR BLOCKADE WITH PHENTOLAMINE-OXPRENOLOL OR WITH LABETALOL (AH5158) [J].
JOHNSON, BF ;
LABROOY, J ;
MUNROFAURE, AD .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 51 :S505-S507
[52]  
KANE J, 1976, BRIT J CLIN PHARMACO, V3, P737
[53]  
KANTO J, 1981, INT J CLIN PHARM TH, V19, P41
[54]   BIOAVAILABILITY OF LABETALOL INCREASES WITH AGE [J].
KELLY, JG ;
MCGARRY, K ;
OMALLEY, K ;
OBRIEN, ET .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :304-305
[55]   EFFECTS OF CHRONIC ALPHA AND BETA ADRENOCEPTOR BLOCKADE WITH LABETALOL ON PLASMA-CATECHOLAMINES AND RENAL-FUNCTION IN HYPERTENSION [J].
KEUSCH, G ;
WEIDMANN, P ;
ZIEGLER, WH ;
CHATEL, RD ;
REUBI, FC .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (01) :25-29
[56]   FALSELY HIGH URINARY CATECHOLAMINES INDUCED BY LABETALOL [J].
KOBAYASHI, K ;
TOMIOKA, H ;
MIURA, Y ;
YOSHINAGA, K ;
ABE, K ;
SAKUMA, H ;
ADACHI, M .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 127 (01) :63-69
[57]  
KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P729
[58]  
KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P725
[59]  
KOCH G, 1979, BRIT HEART J, V41, P192